Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cyclerion Therapeutics Inc
CYCNCurrent price
3.25 USD
+0.21 USD (+6.91%)
Last closed
2.95 USD
Company
www.cyclerion.com
ISIN
US23255M1053
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
7 663 219 USD
Yield for 12 month
+5.52 %
1Y
3Y
5Y
10Y
15Y
CYCN
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Address: 245 First Street, Riverview II, Cambridge, MA, United States, 02142
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.00 USDP/E ratio
–Dividend Yield
–Current Year
+2 000 000 USD
Last Year
–
Current Quarter
+1 806 000 USD
Last Quarter
+194 000 USD
Current Year
+2 000 000 USD
Last Year
–
Current Quarter
+1 806 000 USD
Last Quarter
+194 000 USD
Key Figures CYCN
1 year
3 years
5 years
10 years
EBITDA
-9 582 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-19.76 %
PEG Ratio
–
Return On Equity TTM
-30.36 %
Wall Street Target Price
4.00 USD
Revenue TTM
2 000 000 USD
Book Value
3.48 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
14.10 %
Dividend Yield
–
Gross Profit TTM
2 000 000 USD
Earnings per share
-1.25 USD
Diluted Eps TTM
-1.25 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-152.85 %
Dividend Analytics CYCN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History CYCN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:20
Payout Ratio TTM
–
Last Split Date
16.05.2023
Stock Valuation CYCN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.22
Price Sales TTM
3.83
Enterprise Value EBITDA
0.56
Price Book MRQ
0.87
Financials CYCN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CYCN
For 52 weeks
1.27 USD
9.47 USD
50 Day MA
2.69 USD
Shares Short Prior Month
70 843
200 Day MA
2.90 USD
Short Ratio
1.18
Shares Short
41 890
Short Percent
2.48 %
BeatStart